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The practice of immersion in burn patient has been abandoned in many parts of the world but in Brazil it 
is still common. The aim of this study was to ascertain if balneotherapy is a risk factor for Pseudomonas 
aeruginosa colonization in thermally injured patients. Eighteen patients from a Burn Center were studied 
for 14 weeks for Pseudomonas aeruginosa. Samples were collected by swabbing the exudate of wounds, 
before and after giving bath to the patients and from balneotherapy table. Pulsed-field gel electrophoresis 
was used to determine bacterial genetic relatedness. Thirty-seven P. aeruginosa isolates were detected 
from 292 swabs collected from patients’ burn surface area and from the balneotherapy table. Profile 
analysis of P. aeruginosa DNA fragmentation showed 10 clones among the 37 strains analyzed. Type 
A is the most prevalent clone, with 23 strains distributed into eight subtypes. These were present in 
the swabs collected, before and after the patients’ bath, from the surface of the bath table, suggesting 
that there was cross-contamination between the patients in different ways. This work demonstrates that 
balneotherapy is a risk factor in the Burn Center studied, because the same clone was found among 
P. aeruginosa isolates collected at various points and times.
Uniterms: Pseudomonas aeruginosa/colonization. Burn patients. Balneotherapy. PFGE.
A prática de balneotarapia em paciente queimado foi abandonada em muitas partes do mundo, mas no 
Brasil ainda é comum. O objetivo deste estudo foi verificar se a balneoterapia é um fator de risco para 
a colonização por Pseudomonas aeruginosa em pacientes queimados. Dezoito pacientes internados 
em um Centro de Queimadura (CQ) foram acompanhados por 14 semanas. Amostras foram coletadas 
do exsudato de feridas, antes e depois do banho dos pacientes e também da mesa onde a balneoterapia 
foi realizada. A relação genética entre as cepas de P. aeruginosa foi determinada pela electroforese em 
gel de campo pulsado. Trinta e sete cepas foram detectadas a partir de 292 swabs coletados de área de 
superfície das feridas dos pacientes e da mesa de balneoterapia. Análise de fragmentação do DNA das 
37 P. aeruginosa mostrou a existência de 10 clones. O tipo A foi o clone mais prevalente, com 23 cepas 
distribuídas em oito subtipos. Estas estavam presentes nas lesões dos pacientes antes e após o banho e 
na mesa onde o banho foi realizado, sugerindo contaminação cruzada inter e intra-pacientes e pacientes 
e mesa de banho. Este trabalho mostra que a balneoterapia é um fator de risco para colonização por 
P. aeruginosa, no CQ estudado, pois um mesmo clone da bactéria foi encontrado nos isolados coletados 
em vários pontos e épocas diferentes.
Unitermos: Pseudomonas aeruginosa/colonização. Pacientes queimados/tratamento. Balneoterapia. 
Eletroforese em campo pulsado.
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INTRODUCTION
Infection is a major cause of morbidity and mortality 
of burn patients (Elmanama et al., 2013; Mahar et al., 
2010). These patients are highly susceptible to infections, 
because by then they have lost the integrity of the skin, 
the first barrier of protection against infectious agents. 
Besides, they may require hospitalization for long periods, 
which increases the risk of infection (Church et al., 2006). 
 Balneotherapy or hydrotherapy in burn patient 
can be done in designated areas only that ensure control 
and prevention of infection. The burn wound is washed 
and scrubbed with water and degermed by a spray hose. 
During this procedure, topical agents, necrotic tissue and 
microorganisms are removed (Kowalske, 2011). However, 
the practice of immersion has been abandoned in many 
parts of the world. Notwithstanding, in some Burn Center 
(BC) in Brazil it is still used.
Some authors consider that colonization of the 
burned area does not necessarily represent a risk factor for 
infection (Tredget et al., 2004; Wang et al., 2010). But, 
when there is contamination of the living tissue underlying 
the injury, with clinical signs of inflammatory reaction 
and browning, one can infer that the burned surface area 
(BSA) is infected and may lead to a systemic infection 
(Ulkur et al., 2005).
In burn patients, particularly those with severe 
burns, P. aeruginosa can cause a great variety of systemic 
infections, such as urinary tract infection, respiratory 
system infection, dermatitis, soft tissue infection, 
bacteremia, bone and joint infection and gastrointestinal 
infection (Taneja et al., 2013; Yali et al., 2013). Burned 
patients present an immunosuppression condition; they 
consequently have higher susceptibility to infections by 
P. aeruginosa, with a high mortality rate. In addition, 
as prevention and control of P. aeruginosa infections 
continue to be serious nosocomial problems worldwide, 
treatment of P. aeruginosa infections is a serious medical 
challenge especially in burned patients (Taneja et al., 
2013; Yali et al., 2013; Fallah et al., 2013).
Therefore, prophylaxis with antibiotics is used for 
preventing or reducing the risk of infections in thermally 
injured patients (Barajas-Nava et al., 2013). Some 
antibiotics are used locally on the skin (topical treatment), 
while others are taken systemically. 
Silver sulfadiazine (SSD) cream is one of the topical 
agents that is most commonly used as an adjuvant in the 
prevention and treatment of wound infections in patients 
with severe burns. In addition, it has broad antimicrobial 
spectrum on microorganisms found on BSA, with prolonged 
action. It is believed that bacteriostatic and bactericidal 
effect of SSD increases when it is associated with 0.4% 
cerium nitrate (De Gracia, 2001; Eski et al., 2011). 
Molecular methods are often used in epidemiologic 
studies to monitor the spread of a particular strain in the 
same patient or environment or between different patients 
and environments. From such monitoring, it is possible to 
decipher the transmission routes of the bacteria (Nonaka 
et al., 2010). Pulse-field gel electrophoresis (PFGE) is a 
gold standard genotypic technique for P. aeruginosa (Hu 
et al., 2013; Nonaka et al., 2010). 
The aims of this study were to assess the role of the 
balneotherapy as a risk factor for burned patient as well 
to investigate the colonization by P. aeruginosa in the 
same patients to evaluate the efficacy of balneotherapy in 
its elimination.
STUDY SETTING
The BC studied belongs to a hospital in Rio de 
Janeiro city, Brazil. This center has 12 beds, of which eight 
are for adult patients and four for children. Generally, the 
patient’s hospital stay is prolonged, ranging from 30 to 
180 days. 
At this center, we conducted an observational 
study for 14 weeks (September to December 2012) with 
prospective analysis. The inclusion criteria for the subjects 
of study were adult patients (+18 years old) admitted to 
the BC, whose bath samples can be collected at least on 
two different days. 
METHODS
Management of burn patients
At this burn unit, all patients, after disinfecting the 
burned area with a degerming application, are submitted to 
a daily balneotherapy session. However, in this paper only 
one table was studied and approximately 5 to 6 patients 
received sequential treatments in the immersion table. 
SSD is applied for topical treatment of both superficial and 
deep burns. The Human Research Ethics Committee from 
HUAP at Universidade Federal Fluminense approved this 
study by number 68538.
Bacterial isolates and identification
Samples from burn surface area (BSA) were 
collected every Monday from each patient by swabbing the 
exudate of wounds immediately after removing the SSD 
dressing, but before giving bath to the patient. After giving 
bath and before SSD dressing, samples were collected 
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again from the previous sampling points, regardless of the 
clinical condition of the patients. Prior to sampling, the 
wound was rinsed with sterile saline 0.9% to eliminate any 
trace of SSD, which is applied daily for topical treatment. 
Swabs also were collected from the table where 
balneotherapy was realized, before each bath and after the 
last bath. Between every two baths, a cleaning procedure 
was performed by the cleaning staff. Water analysis was 
performed once a month.
All swabs were inoculated into 2 mL of salt 
solution (0.9%), vortex and 1 mL was introduced into 
Tryptone Soya Broth (TSB; HIMEDIA, India) in double 
concentration. The samples were incubated at 35 °C (± 2) 
for 24 to 48 hours. The tubes that showed turbid medium 
were screwed onto cetrimide agar (HIMEDIA, India) 
and incubated again at the same conditions mentioned 
above. The colonies that could grow in cetrimide agar 
were submitted to testing for P. aeruginosa, using the 
standard biochemical tests. All the isolates were kept on 
crioprotector medium at -20 °C. To confirm detection of P. 
aeruginosa, polimerase chain reaction (PCR) was carried 
out according to Spilker et al. (2004).
Determination of minimal inhibitory 
concentration (MIC)
The MIC values were determined by agar 
microdilution method, using Pseudomonas aeruginosa 
ATCC 27853 as microorganism control. Muller Hinton 
agar (MHA) medium (DIFCO LABORATORIES, USA) 
was prepared with serial diluted concentrations of SSD 
(PHARMA NOSTRA, India) incorporated into agar. 
Steers replicator was used to transfer the inoculum to the 
plate.
Characterization of the isolates by PFGE
Clonal relatedness of the isolates was evaluated by 
PFGE as described previously (Gautom et al., 1997), using 
the SpeI restriction enzyme instead of XbaI performed 
in a contour-clamped homogeneous-electric-field DRIII 
apparatus (Bio-Rad Laboratories, Hercules, CA., USA). 
The clonality was determined by visual analysis using 
Tenover criterion (Tenover et al., 1995).
Statistical analysis
Descriptive statistics was used for exploratory 
analysis of the variables involved in balneotherapy, and 
McNemar, a non-parametric test, was employed for risk 
factors analysis.
RESULTS
The results concerning the balneotherapy of 18 
patients, for 14 weeks, were analyzed. Seventy baths, with 
a mean of 5 (± 0.6) patients per day bath, were monitored. 
The average time spent by a patient in each balneotherapy 
session was 29 minutes. 
From the 292 swabs studied, 37 strains were 
identified as P. aeruginosa; of these, 28 strains were 
collected from BSA and nine from the balneotherapy table 
surface (BTS). Nine patients (50%) showed no bacterial 
colonization at any time of the study. Ages of the patients 
varied from 19 to 77 years (mean age=41, sd=18), but 
no extreme age patient was present in the group where P. 
aeruginosa was identified.
The gender distribution of the 18 patients tested 
was equitable (50% males and 50% females). Despite 
the isolates being few, it is remarkable that six out of 
nine patients, who tested positive for P. aeruginosa, 
were females. No relationship was observed between the 
percentages of BSA and colonization by P. aeruginosa, 
because patients with both 8.5% and 80% BSA were 
colonized by this microorganism. In addition, of the 28 
P. aeruginosa isolates found in BSA, 20 were detected in 
female patients (Table I).
No P. aeruginosa isolates were detected in the water 
used for bathing the patients or in the material used to 
clean the table. Temporality assessment of P. aeruginosa 
colonization reveals an increase in bacteria during the last 
weeks of the study. 
The first P. aeruginosa detected in this study was 
isolated from BSA and obtained on the fourth bath-day 
(day which the swab was collected) from the third patient 
before being submitted to the procedure.
The analysis of the total DNA fragmentation profile 
by PFGE demonstrated the existence of 10 clones among 
37 strains of P. aeruginosa strains analyzed. Clone A was 
the most prevalent with 23 strains (62%), distributed into 
08 subtypes (A1-A8). The majority of the patients were 
colonized by clone A in different moments of the study, 
except the patient 8 and 9 (P8 and P9; Figure 1). This clone 
was also found on the table surface after the balneotherapy 
sessions 13 and 14 (Table I). 
Other PFGE patterns were also found and designated 
as C, D, E, F, G, H, I and J. Profiles classified as C, D, G, 
H and I were detected only in the BSA of patients, and H 
and J on the table (Table I). Three patients (P10, P11 and 
P17) had P. aeruginosa identified several times during the 
study (Figure 1). PFGE pattern could not be determined 
by SpeI in two samples (Table I).
The temporal analysis suggested the ineffectiveness 
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of the balneotherapy (Figure 1), although the number of 
samples did not allow the identification of a significant 
statistical difference neither for the bath (odds ratio=1.200; 
0.305 < CI 95% < 4.971; p = 1.0000) nor for the table 
(odds ratio= 0.333; 0.006< CI 95% < 4.151; p = 0.6171) 
as a risk factor.
In addition, this analysis could also show as P. 
aeruginosa was spread to different patients. The subtype 
A2 was found in different patients (P6, P10, P11 and 
P16) and in different moments. Similarly, the subtype A3 
was found after and before the P11 bath. These examples 
suggest the hydrotherapy was not effective (Table I). 
Because silver sulfadiazine was extensively used in 
the treatment of burned patients, MIC for this antimicrobial 
was determined for 37 P. aeruginosa isolated in this study. 
The results demonstrated that MIC values ranged from 
32 mg/L to 128 mg/L; 
32 mg/L in eight isolates, 64 mg/L in four and 
128 mg/L in most isolates (Table I).
DISCUSSION
P. aeruginosa, an important source of nosocomial 
infections, can be acquired in a community or hospital 
setting. It is the most common opportunistic pathogen 
to infect hospitalized burn patients (Fallah et al., 2013; 
Ackerman et al., 2013). According to Ackerman et al (2013), 
patients with severe burns have immunosuppression, and 
consequently, increased susceptibility to nosocomial 
infections by P. aeruginosa, resulting in high mortality 
rates, mainly because of their high intrinsic resistance to 
many antibiotics. 
In this study, 37 P. aeruginosa isolates were detected 
from the BSA of 9 out of 18 patients. In addition, this 
microorganism was identified on the table surface where 
balneotherapy occurred. 
Although in this study we observed P. aeruginosa 
colonizing more female patients, we could not investigate 
the role of gender as a risk factor, owing to the small 
number of patients with Pseudomonas colonization. 
Moreover, some authors find no significant statistical 
difference between the results of patient cultures and their 
genders (Al Laham et al., 2013). 
Molecular typing methods using PFGE are important 
tools for epidemiological studies (Ballarini et al., 2012; 
Mudau et al., 2013). The similarity between strains allows 
determination of the source of an outbreak, and facilitates 
implementation of effective control measures (Mudau et 
al., 2013).
In this work, we detected one clone (named A) as a 
major P. aeruginosa clone spread during all period of the 
study (Figure I). This clone was found on the surface of 
the table among multiple procedures and on BSA patient 
suggesting transmission of the isolate from table to patient 
(Table I). 
Persistence of clones of P. aeruginosa in the hospital 
environment has been discussed by several authors 
(Tredget et al., 2004; Wolska et al., 2012; Johansson 
el al., 2014). Analysis of table surface demonstrates 
possible cross-transmission of the microorganism during 
FIGURE 1 - Temporal analysis of the Pseudomonas aeruginosa found in the patient´s swabs.
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TABLE I - Characterization of the 37 colonizing Pseudomonas aeruginosa 
Isolate
Patient report Collection 
date
Collection 




1 F 30% 23 10/08/2012 bP6 Before bath A1 128
2 M 48% 48 10/15/2012 P8 After bath D 128
3 10/15/2012 P6 Before bath A2 128
4 - - - 10/22/2012 cBTS Final cleanup E 128
5 M 80% 25 11/12/2012 P9 After bath NT 128
6 F 30% 34 11/19/2012 P10 After bath A2 128
7 F 44,5% 24 11/26/2012 P11 Before bath F 32
8 11/26/2012 P11 After bath A2 64
9 F 8,5% 27 11/26/2012 P16 After bath A2 128
10 12/03/2012 P10 After bath A5 128
11 12/03/2012 P11 Before bath A6 128
12  M 18% 54 12/03/2012 P17 Before bath A6 128
13 12/03/2012 P17 After bath G 32
14 F 18,5% 59 12/03/2012 P15 Before bath H 128
15 12/03/2012 P15 After bath A1 128
23 - - - 12/10/2012 BTS First cleanup before 
the patients’ baths
A1 32
16 12/10/2012 P10 Before bath I 128
17 12/10/2012 P10 After bath A4 64
24 - - - 12/10/2012 BTS After the first bath A1 128
18 F 14% 34 12/10/2012 P12 Before bath A4 128
19 12/10/2012 P12 After bath H 64
25 - - - 12/10/2012 BTS After the second bath - 128
20 12/10/2012 P17 Before bath A7 128
26 - - - 12/10/2012 BTS After the third bath A1 32
21 12/10/2012 P11 Before bath A1 128
22 12/10/2012 P11 After bath A8 128
27 - - - 12/10/2012 BTS After the fourth bath A2 128
28 - - - 12/10/2012 BTS After the fifth bath A1 128
31 12/18/2012 P8 Before bath C 128
32 12/18/2012 P8 After bath NT 64
33 12/18/2012 P17 After bath A1 128
38 - - - 12/18/2012 BTS After the third bath J 32
34 12/18/2012 P11 Before bath A3 128
35 12/18/2012 P11 After bath A3 32
39 - - - 12/18/2012 BTS After the fourth bath F 32
36 12/18/2012 P10 Before bath A5 128
aBSA: burn surface area. bP: patient identification. cBTS: isolates collected from the balneotherapy table surface. dPFGE: pulsed-
field gel electrophoresis pattern. eMIC: minimal inhibitory concentration.
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balneotherapy procedure (Table I). This microorganism 
is known for its ability to adhere to both biological 
cell membranes and inert surfaces, mediated through 
the pili and by the production of large amounts of 
exopolysaccharides (Pier et al., 1987). In addition, this 
microorganism has strong capability to develop multidrug 
resistance to many drugs (Ackerman et al., 2013; Shanthi et 
al., 2013). Additionally, Tredget et al. (2004) demonstrated 
that P. aeruginosa clinical isolates, belonging to the same 
clone, were present in both the patients and the sink trap. 
In this study, transmissions from patient to patient and 
patient to balneotherapy table were verified. It seems that 
some isolates have greater ability to persist and fit better 
in the environment at the expense of others (Elmanama et 
al., 2013). In this study, although only a few isolates were 
detected, we can verify the predominant clone persisted for 
14 weeks (Figure 1). Possibly, the clone is better adapted 
to the conditions of the study.
Analys is  of  the  f requency of  subtype  A2 
demonstrates the transmission of the isolate between 
two patients (Table I), besides confirming the isolate’s 
ability to persist. A3 subtype isolate demonstrates the 
ineffectiveness of balneotherapy for decolonization, 
because the same isolate was found before and after 
balneotherapy of the same patient. 
Regardless of clonality, evaluating contamination 
by P. aeruginosa as a risk factor might deserve attention. 
Although no statistically significant relationship could 
be observed among balneotherapy procedures, probably 
because of fewer patients and fewer events, the fact that 
six patients, who were not contaminated before bathing, 
became contaminated after bathing, suggests that bathing 
can be considered a clinically risk factor. In addition, 
eight patients who were found as contaminated before 
balneotherapy remained so even after bathing (Figure 1). 
This leads one to believe that neither the procedure nor the 
degermant allowed decontamination. This observation is 
reinforced by the genetic profile analysis of DNA bacteria 
showing similarity among isolates collected at points and 
different moments.
The risks associated with the ways the injury is 
taken care of, such as daily bath, can be related to the 
source of water (tap, hose or shower), which is frequently 
contaminated with microorganisms of the environment, 
such as bodies of other patients (Tredget et al., 2004). For 
this study, besides the bath table, the water used was also 
evaluated and no contamination by P. aeruginosa was 
observed.
Silver sulfadiazine serves better to prevent wounds 
colonization/infection and therefore is the best choice to 
reduce the risk of sepsis, a serious complication and a 
major threat to burn victims with large burns (Shanthi et 
al., 2014; Hajska et al., 2014). At the BC studied, SSD 
agent was used as a dressing reference standard therapy. It 
is important to note that in this study, 64% of the isolates 
tested showed MIC of 128 mg/L (Table I). This suggests 
decreased susceptibility of the bacteria in comparison to 
the findings of a study conducted in 1973, in New York, 
which reports that 100% of the strains of P. aeruginosa 
infection of skin had MIC of 50 mg/L and 60% of the 
isolates tested showed MIC of 6.25 mg/L (Carr et al., 
1973). We suggest that the wide use of this topical agent 
could select more resistant strains to this antimicrobial.
CONCLUSION
The temporal analysis of balneotherapy in 
decolonization of SCQ by strains of P. aeruginosa shows 
that this procedure is not effective for decontamination 
of patients and table. On the surface of the table where 
the baths were realized, clones of the same subtype of P. 
aeruginosa were found, suggesting that the table was not 
being adequately disinfected. In addition, clones of the 
same subtype of P. aeruginosa were found, before and 
after bathing, in different burn areas of the same patient. 
This suggests cross-contamination between patients. 
The MIC values obtained in this study for silver 
sulfadiazine are rather higher in comparison to those 
reported in different decades, suggesting that other 
techniques must be used for topical treatment of burned 
patients.
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